Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Altropane phase II protocol for ADHD diagnosis submitted to FDA

Nov. 25, 1999

Palatin Technologies submits BLA for LeuTech imaging agent

Nov. 24, 1999

NeXstar presents aptamer against tenascin-C with potential for cancer imaging and therapy

Nov. 23, 1999

Phase II trials initiated with MRE-0470 as CAD diagnostic

Nov. 18, 1999

Sonus restructures EchoGen marketing agreement with Abbott

Nov. 17, 1999

Optimal timing of cardiac imaging with 99mTc-NOET

Nov. 17, 1999

InSite Vision licenses glaucoma diagnosis technology to Pharmacia & Upjohn

Nov. 17, 1999

Draximage licenses Amiscan AMI diagnostic

Nov. 15, 1999

Palatin-Molecular Biosystems merger will create stronger new diagnostic company

Nov. 15, 1999

Prognox effectively detects hypoxic tissue; kinetics differ in stunned and hibernating myocardium

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...